Review ArticleReview Article
Pharmacogenomic Discovery Using Cell-Based Models
Marleen Welsh, Lara Mangravite, Marisa Wong Medina, Kelan Tantisira, Wei Zhang, R. Stephanie Huang, Howard McLeod and M. Eileen Dolan
Pharmacological Reviews December 2009, 61 (4) 413-429; DOI: https://doi.org/10.1124/pr.109.001461
Marleen Welsh
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
Lara Mangravite
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
Marisa Wong Medina
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
Kelan Tantisira
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
Wei Zhang
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
R. Stephanie Huang
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
Howard McLeod
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
M. Eileen Dolan
Department of Medicine, University of Chicago, Chicago, Illinois (M.W., W.Z., S.H., M.E.D.); Center for Prevention of Obesity, Cardiovascular Disease, and Diabetes, Children's Hospital Oakland Research Institute, Oakland, California (L.M., M.W.M.); Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (K.T.); and Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina Chapel Hill, Chapel Hill, North Carolina (H.M.)
PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Review ArticleReview Article
Pharmacogenomic Discovery Using Cell-Based Models
Marleen Welsh, Lara Mangravite, Marisa Wong Medina, Kelan Tantisira, Wei Zhang, R. Stephanie Huang, Howard McLeod and M. Eileen Dolan
Pharmacological Reviews December 1, 2009, 61 (4) 413-429; DOI: https://doi.org/10.1124/pr.109.001461
Review ArticleReview Article
Pharmacogenomic Discovery Using Cell-Based Models
Marleen Welsh, Lara Mangravite, Marisa Wong Medina, Kelan Tantisira, Wei Zhang, R. Stephanie Huang, Howard McLeod and M. Eileen Dolan
Pharmacological Reviews December 1, 2009, 61 (4) 413-429; DOI: https://doi.org/10.1124/pr.109.001461
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement